These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38576645)

  • 21. Factors associated with implantable cardioverter defibrillators appropriate therapy in cardiac sarcoidosis: a meta-analysis.
    Azoulay LD; Waintraub X; Haroche J; Amoura Z; Cohen Aubart F
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(1):17-23. PubMed ID: 33093765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure.
    Fudim M; Ali-Ahmed F; Parzynski CS; Ambrosy AP; Friedman DJ; Pokorney SD; Curtis JP; Fonarow GC; Masoudi FA; Hernandez AF; Al-Khatib SM
    JAMA Cardiol; 2020 Jun; 5(6):643-651. PubMed ID: 32211811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes?
    Ambrosy AP; Parzynski CS; Friedman DJ; Fudim M; Hernandez AF; Fonarow GC; Masoudi FA; Al-Khatib SM
    Circulation; 2018 Dec; 138(24):2787-2797. PubMed ID: 30565983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice.
    Masoudi FA; Go AS; Magid DJ; Cassidy-Bushrow AE; Doris JM; Fiocchi F; Garcia-Montilla R; Glenn KA; Goldberg RJ; Gupta N; Gurwitz JH; Hammill SC; Hayes JJ; Jackson N; Kadish A; Lauer M; Miller AW; Multerer D; Peterson PN; Reifler LM; Reynolds K; Saczynski JS; Schuger C; Sharma PP; Smith DH; Suits M; Sung SH; Varosy PD; Vidaillet HJ; Greenlee RT
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):e78-85. PubMed ID: 23170006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region.
    Hoang A; Shen C; Zheng J; Taylor S; Groh WJ; Rosenman M; Buxton AE; Chen PS
    Heart Rhythm; 2014 May; 11(5):849-55. PubMed ID: 24566233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender Differences in Rates of Arrhythmias, Cardiac Implantable Electronic Devices, and Diagnostic Modalities Among Sarcoidosis Patients.
    Durugu S; Gonuguntla K; Patil S; Rojulpote C; Vyata V; Karambelkar P; Narayanareddy P; Vuthaluru K; Bhattaru A
    Cureus; 2020 Apr; 12(4):e7667. PubMed ID: 32419995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Outcomes of Subcutaneous or Transvenous Implantable Cardioverter-Defibrillators in Older Patients.
    Friedman DJ; Qin L; Parzynski C; Heist EK; Russo AM; Ranasinghe I; Zeitler EP; Minges KE; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
    J Am Coll Cardiol; 2022 Mar; 79(11):1050-1059. PubMed ID: 35300816
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow-up of implantable cardioverter-defibrillators in children: Indications and outcomes.
    Kwiatkowska J; Budrejko S; Wasicionek M; Meyer-Szary FJ; Lubinski A; Kempa M
    Adv Clin Exp Med; 2020 Jan; 29(1):123-133. PubMed ID: 31895976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Systematic Review and Meta-Analysis of Randomized Trials and Propensity Score-Matched Studies.
    Fong KY; Ng CJR; Wang Y; Yeo C; Tan VH
    J Am Heart Assoc; 2022 Jun; 11(11):e024756. PubMed ID: 35656975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Term Clinical Outcomes of Subcutaneous Versus Transvenous Implantable Defibrillator Therapy.
    Brouwer TF; Yilmaz D; Lindeboom R; Buiten MS; Olde Nordkamp LR; Schalij MJ; Wilde AA; van Erven L; Knops RE
    J Am Coll Cardiol; 2016 Nov; 68(19):2047-2055. PubMed ID: 27810043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term monitoring of arrhythmias with cardiovascular implantable electronic devices in patients with cardiac sarcoidosis.
    Bakker A; Mathijssen H; Dorland G; Balt JC; van Dijk VF; Veltkamp M; Akdim F; Grutters JC; Post MC
    Heart Rhythm; 2022 Mar; 19(3):352-360. PubMed ID: 34843965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous versus transvenous implantable defibrillator: An updated meta-analysis.
    Rordorf R; Casula M; Pezza L; Fortuni F; Sanzo A; Savastano S; Vicentini A
    Heart Rhythm; 2021 Mar; 18(3):382-391. PubMed ID: 33212250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.
    Colquitt JL; Mendes D; Clegg AJ; Harris P; Cooper K; Picot J; Bryant J
    Health Technol Assess; 2014 Aug; 18(56):1-560. PubMed ID: 25169727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
    Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
    Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex Differences in Outcomes of Tetralogy of Fallot Patients With Implantable Cardioverter-Defibrillators.
    Waldmann V; Bouzeman A; Duthoit G; Koutbi L; Bessière F; Labombarda F; Marquié C; Gourraud JB; Mondoly P; Sellal JM; Bordachar P; Hermida A; Al Arnaout A; Anselme F; Audinet C; Bernard Y; Boveda S; Bun SS; Chassignolle M; Clerici G; Da Costa A; de Guillebon M; Defaye P; Elbaz N; Eschalier R; Garcia R; Guenancia C; Guy-Moyat B; Halimi F; Irles D; Iserin L; Jourda F; Ladouceur M; Lagrange P; Laredo M; Mansourati J; Massoulié G; Mathiron A; Maury P; Messali A; Narayanan K; Nguyen C; Ninni S; Perier MC; Pierre B; Pujadas P; Sacher F; Sagnol P; Sharifzadehgan A; Walton C; Winum P; Zakine C; Fauchier L; Martins R; Pasquié JL; Thambo JB; Jouven X; Combes N; Marijon E
    JACC Clin Electrophysiol; 2022 Oct; 8(10):1304-1314. PubMed ID: 36266008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial differences in setting of implantable cardioverter-defibrillator placement in older adults with heart failure and association with disparate post-implant outcomes.
    Akhabue E; Kuhrt N; Gandhi P; Rua M; Shalmon U; Visaria A; Jackson LR; Setoguchi S
    Front Cardiovasc Med; 2023; 10():1197353. PubMed ID: 37724120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Applicability of the AHA/ACC/HRS Guideline for Implantable Cardioverter Defibrillator Implantation in Japanese Patients With Cardiac Sarcoidosis.
    Takenaka S; Kobayashi Y; Nagai T; Kato Y; Komoriyama H; Nagano N; Kamiya K; Konishi T; Sato T; Omote K; Mizuguchi Y; Tada A; Sato T; Iwano H; Kusano K; Ishibashi-Ueda H; Anzai T
    JACC Clin Electrophysiol; 2021 Nov; 7(11):1410-1418. PubMed ID: 34217654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual- vs. single-chamber defibrillators for primary prevention of sudden cardiac death: long-term follow-up of the Défibrillateur Automatique Implantable-Prévention Primaire registry.
    Defaye P; Boveda S; Klug D; Beganton F; Piot O; Narayanan K; Périer MC; Gras D; Fauchier L; Bordachar P; Algalarrondo V; Babuty D; Deharo JC; Leclercq C; Marijon E; Sadoul N;
    Europace; 2017 Sep; 19(9):1478-1484. PubMed ID: 28340096
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.